Mércia Pandolfo Provin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mércia Pandolfo Provin has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Ana Carolina Figueiredo Modesto
Postgraduate Program in Pharmaceutical Sciences - University of Sorocaba, Sorocaba, Brazil
5 shared publications - Rita Goreti Amaral
School of Pharmacy, Federal University of Goiás, Goiás 74605-170, Brazil
5 shared publications - Dione Marçal Lima
School of Pharmacy, Federal University of Goiás, Goiás 74605-170, Brazil
4 shared publications - Rita Goreti Amaral
Universidade Federal de Goiás. Faculdade de Farmácia. Goiânia, GO, Brasil
3 shared publications - Ana Laura de Sene Amâncio Zara
Universidade Federal de Goiás image/svg+xml
2 shared publications - Cristiano Manetti da Cruz
Farmácia Municipal da Prefeitura Municipal de Canguçu, Canguçu, Rio Grande do Sul, Brasil
2 shared publications
Latest Publications
- Open Access
- 31 January 2025
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 10 (1)
The effects of judicialization on the budget of the Municipal Health Department of Canguçu/RS
Objectives: To identify expenses with the purchase of medicines and supplies by the Municipal Health Department of Canguçu/RS, through legal proceedings, from 2017 to 2021. Methods: It is a quantitative, descriptive, and retrospective study, using the docu-ment analysis technique. Secondary data on public costs, available on the Transparency Portal, were used. The amounts spent and the origins of the resources used for the acqui-sition of these drugs were analyzed. Results: There was an increase of 297.93% in spen-ding on legal proceedings for the acquisition of medicines and pharmaceutical supplies through judicial blockades. Of these, more than 76% refer to antineoplastic medications. The basic care budget increased by 132.41% in this period and the costs of pharmaceu-tical assistance almost doubled from R$ 854,248.86, in 2017, to R$ 1,524,871.92, in 2021, with a significant increase during the pandemic period. Comparing the expen-diture on purchasing medicines through blockages by court permits in 2021 and the amount spent on pharmaceutical assistance in the same period, it is noted that the cost is very similar, but a small portion of the population is served through judicialization. Conclusions: There was a considerable increase in spending on purchasing medicines due to court decisions. The Municipal Health Department is obliged to acquire medicines that do not belong to the Municipal Medication List, through judicial blocking of public accounts, because the government of the State of Rio Grande do Sul does not send these medicines to users with approved lawsuits.
- 31 January 2025
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 10 (1)
Open AccessThe effects of judicialization on the budget of the Municipal Health Department of Canguçu/RS
Objectives: To identify expenses with the purchase of medicines and supplies by the Municipal Health Department of Canguçu/RS, through legal proceedings, from 2017 to 2021. Methods: It is a quantitative, descriptive, and retrospective study, using the docu-ment analysis technique. Secondary data on public costs, available on the Transparency Portal, were used. The amounts spent and the origins of the resources used for the acqui-sition of these drugs were analyzed. Results: There was an increase of 297.93% in spen-ding on legal proceedings for the acquisition of medicines and pharmaceutical supplies through judicial blockades. Of these, more than 76% refer to antineoplastic medications. The basic care budget increased by 132.41% in this period and the costs of pharmaceu-tical assistance almost doubled from R$ 854,248.86, in 2017, to R$ 1,524,871.92, in 2021, with a significant increase during the pandemic period. Comparing the expen-diture on purchasing medicines through blockages by court permits in 2021 and the amount spent on pharmaceutical assistance in the same period, it is noted that the cost is very similar, but a small portion of the population is served through judicialization. Conclusions: There was a considerable increase in spending on purchasing medicines due to court decisions. The Municipal Health Department is obliged to acquire medicines that do not belong to the Municipal Medication List, through judicial blocking of public accounts, because the government of the State of Rio Grande do Sul does not send these medicines to users with approved lawsuits.
- Open Access
- 31 January 2025
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 10 (1)
Os efeitos da judicialização no orçamento da Secretaria Municipal de Saúde de Canguçu/RS
Objetivos: Identificar os gastos com a compra de medicamentos e insumos pela Secretaria Municipal de Saúde (SMS) de Canguçu/RS, mediante processos judiciais, no período de 2017 a 2021. Métodos: É um estudo quantitativo descritivo e retrospectivo, com utilização da técnica de análise documental. Foram utilizados dados secundários dos custos públicos, disponíveis no Portal da Transparência. Foram analisados os valores gastos e as origens dos recursos utilizados para a aquisição desses medicamentos. Resultados: Houve um aumento de 297,93% nos gastos com processos judiciais para aquisição de medicamentos e insumos farmacêuticos por meio de bloqueios judiciais. Desses, mais de 76% referem-se a medicamentos antineoplásicos. O orçamento executado da Atenção Básica aumentou 132,41% nesse período e os custos com a assistência farmacêutica quase dobraram de R$ 854.248,86, em 2017, para R$ 1.524.871,92, em 2021, com aumento significativo no período pandêmico. Comparando-se os gastos com aquisição de medicamentos por meio de bloqueios por alvarás judiciais em 2021 e o valor executado com a assistência farmacêutica no mesmo período, nota-se que o custo é muito semelhante, porém, atende-se uma pequena parcela da população por meio da judicialização. Conclusões: Houve um aumento considerável nos gastos com aquisição de medicamentos por meios judiciais. A Secretaria Municipal de Saúde é obrigada a adquirir os medicamentos não pertencentes à Relação Municipal de Medicamento, mediante bloqueios judiciais de contas públicas, porque o governo do Estado do Rio Grande do Sul não envia esses medicamentos aos usuários com processos judiciais deferidos.
- 31 January 2025
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 10 (1)
Open AccessOs efeitos da judicialização no orçamento da Secretaria Municipal de Saúde de Canguçu/RS
Objetivos: Identificar os gastos com a compra de medicamentos e insumos pela Secretaria Municipal de Saúde (SMS) de Canguçu/RS, mediante processos judiciais, no período de 2017 a 2021. Métodos: É um estudo quantitativo descritivo e retrospectivo, com utilização da técnica de análise documental. Foram utilizados dados secundários dos custos públicos, disponíveis no Portal da Transparência. Foram analisados os valores gastos e as origens dos recursos utilizados para a aquisição desses medicamentos. Resultados: Houve um aumento de 297,93% nos gastos com processos judiciais para aquisição de medicamentos e insumos farmacêuticos por meio de bloqueios judiciais. Desses, mais de 76% referem-se a medicamentos antineoplásicos. O orçamento executado da Atenção Básica aumentou 132,41% nesse período e os custos com a assistência farmacêutica quase dobraram de R$ 854.248,86, em 2017, para R$ 1.524.871,92, em 2021, com aumento significativo no período pandêmico. Comparando-se os gastos com aquisição de medicamentos por meio de bloqueios por alvarás judiciais em 2021 e o valor executado com a assistência farmacêutica no mesmo período, nota-se que o custo é muito semelhante, porém, atende-se uma pequena parcela da população por meio da judicialização. Conclusões: Houve um aumento considerável nos gastos com aquisição de medicamentos por meios judiciais. A Secretaria Municipal de Saúde é obrigada a adquirir os medicamentos não pertencentes à Relação Municipal de Medicamento, mediante bloqueios judiciais de contas públicas, porque o governo do Estado do Rio Grande do Sul não envia esses medicamentos aos usuários com processos judiciais deferidos.
- Open Access
- 1 October 2023
- Published by RECIMA21 - Revista Cientifica Multidisciplinar in RECIMA21 - Revista Científica Multidisciplinar
- Vol. 4 (10) , e4104071
VALIDAÇÃO DE INSTRUMENTO PARA MENSURAR A ADESÃO AO TRATAMENTO FARMACOLÓGICO EM PACIENTES PSIQUIÁTRICOS
Objetivo: Validar a Escala de Avaliação da Adesão ao Tratamento Farmacológico em Pacientes Portadores de Transtornos Psiquiátricos (VERUM), desenvolvida para avaliar especificamente os elementos que influenciam a adesão ao tratamento farmacológico em pacientes com Transtornos Mentais, quanto à sua reprodutibilidade, confiabilidade e validade. Métodos: Foram utilizadas técnicas estatísticas para testar a reprodutibilidade da escala (coeficiente H), consistência interna por meio do Alfa de Cronbach e Coeficiente Ômega de Mcdonald, e validade do instrumento através de comparação com a Escala MARS e Análise Fatorial Exploratória. Resultados: Alfa de Cronbach (0,81) e Ômega de Mcdonald (0,826) indicaram que VERUM possui boa consistência interna e a Correlação de Spearman (-0,69) mostrou que há correlação entre os itens de MARS e VERUM. A Análise Fatorial Exploratória agrupou os itens da Escala VERUM em três dimensões que influenciam a adesão do grupo de estudo: ganho secundário, mundo interior e relações com o mundo exterior. Conclusões: Resultados das análises estatísticas mostraram que a Escala VERUM é uma ferramenta válida e confiável para avaliar a adesão ao tratamento farmacológico em pacientes psiquiátricos. As dimensões de adesão organizam-se em fatores que vão além dos reconhecidos na literatura.
- 1 October 2023
- Published by RECIMA21 - Revista Cientifica Multidisciplinar in RECIMA21 - Revista Científica Multidisciplinar
- Vol. 4 (10) , e4104071
Open AccessVALIDAÇÃO DE INSTRUMENTO PARA MENSURAR A ADESÃO AO TRATAMENTO FARMACOLÓGICO EM PACIENTES PSIQUIÁTRICOS
Objetivo: Validar a Escala de Avaliação da Adesão ao Tratamento Farmacológico em Pacientes Portadores de Transtornos Psiquiátricos (VERUM), desenvolvida para avaliar especificamente os elementos que influenciam a adesão ao tratamento farmacológico em pacientes com Transtornos Mentais, quanto à sua reprodutibilidade, confiabilidade e validade. Métodos: Foram utilizadas técnicas estatísticas para testar a reprodutibilidade da escala (coeficiente H), consistência interna por meio do Alfa de Cronbach e Coeficiente Ômega de Mcdonald, e validade do instrumento através de comparação com a Escala MARS e Análise Fatorial Exploratória. Resultados: Alfa de Cronbach (0,81) e Ômega de Mcdonald (0,826) indicaram que VERUM possui boa consistência interna e a Correlação de Spearman (-0,69) mostrou que há correlação entre os itens de MARS e VERUM. A Análise Fatorial Exploratória agrupou os itens da Escala VERUM em três dimensões que influenciam a adesão do grupo de estudo: ganho secundário, mundo interior e relações com o mundo exterior. Conclusões: Resultados das análises estatísticas mostraram que a Escala VERUM é uma ferramenta válida e confiável para avaliar a adesão ao tratamento farmacológico em pacientes psiquiátricos. As dimensões de adesão organizam-se em fatores que vão além dos reconhecidos na literatura.
- Open Access
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 27 (3) , 1205-1221
“A falta de informação nos afasta do remédio, do bem-estar, da harmonia...”: estudo de método misto com demandantes de medicamentos pela via administrativa
Resumo A necessidade de recorrer ao gestor público de saúde para efetivar o direito ao acesso a medicamentos caracteriza a via administrativa. O estudo analisou as percepções dos usuários que acionaram a via administrativa sobre as barreiras para o acesso a medicamentos no setor público de saúde de uma capital brasileira. Foi realizado estudo de método misto com grupo focal, questionário com demandantes e descrição dos medicamentos demandados pela via administrativa. Os resultados apontam a interdependência da assistência farmacêutica com as áreas de interfaceamento para a garantia do acesso. As barreiras relativas aos indivíduos refletem o comprometimento do desenvolvimento da cidadania, justificando o custo do medicamento motivar a demanda. As barreiras à prestação dos serviços contemplam disponibilidade irregular dos medicamentos, insuficiência de recursos e qualidade insatisfatória dos serviços. A dificuldade para conseguir consultas médicas e a exigência da prescrição originada no setor público são barreiras ao setor saúde. As barreiras acima do setor saúde são cumprimento dos procedimentos administrativos, corrupção e clientelismo. A via administrativa intensifica as iniquidades no acesso à saúde no Brasil.
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 27 (3) , 1205-1221
Open Access“A falta de informação nos afasta do remédio, do bem-estar, da harmonia...”: estudo de método misto com demandantes de medicamentos pela via administrativa
Resumo A necessidade de recorrer ao gestor público de saúde para efetivar o direito ao acesso a medicamentos caracteriza a via administrativa. O estudo analisou as percepções dos usuários que acionaram a via administrativa sobre as barreiras para o acesso a medicamentos no setor público de saúde de uma capital brasileira. Foi realizado estudo de método misto com grupo focal, questionário com demandantes e descrição dos medicamentos demandados pela via administrativa. Os resultados apontam a interdependência da assistência farmacêutica com as áreas de interfaceamento para a garantia do acesso. As barreiras relativas aos indivíduos refletem o comprometimento do desenvolvimento da cidadania, justificando o custo do medicamento motivar a demanda. As barreiras à prestação dos serviços contemplam disponibilidade irregular dos medicamentos, insuficiência de recursos e qualidade insatisfatória dos serviços. A dificuldade para conseguir consultas médicas e a exigência da prescrição originada no setor público são barreiras ao setor saúde. As barreiras acima do setor saúde são cumprimento dos procedimentos administrativos, corrupção e clientelismo. A via administrativa intensifica as iniquidades no acesso à saúde no Brasil.
- 1 January 2022
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 16, 1-10
Impediments to deprescription in Brazil: overview from a panel of geriatrics experts
Objectives: To identify impediments to deprescription among older adults from the perspective of a panel of Brazilian geriatricians. Methods: The Delphi method was used to obtain a consensus among Brazilian geriatricians about the factors that influence the lack of deprescription for older adults in clinical practice. The study was developed in two stages: (i) a survey and description of potential factors involved in deprescription; and (ii) applying the results of the survey to a panel of experts to obtain a consensus. Results: The deprescription process is influenced by the interaction of three pillars of older adult health care: the prescriber, the patient-family, and the health care system. In the professional and health care systems, professional training and communication skills, prolonged clinical follow-up, access to the multidisciplinary team, medical consultations of an adequate time, and unified electronic health records were identified as facilitators of deprescription. In the patient-family pillar, clear facilitators included health literacy, no sensory or cognitive deficits, and a clinical situation of transitional or palliative care. Conclusions: Deprescription is a complex, multifactorial process that requires attention, time, and specific skills and competencies from the attending physician, but it also requires shared decision-making and a health system compatible with a culture of deprescription.
- 1 January 2022
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 16, 1-10
Impediments to deprescription in Brazil: overview from a panel of geriatrics experts
Objectives: To identify impediments to deprescription among older adults from the perspective of a panel of Brazilian geriatricians. Methods: The Delphi method was used to obtain a consensus among Brazilian geriatricians about the factors that influence the lack of deprescription for older adults in clinical practice. The study was developed in two stages: (i) a survey and description of potential factors involved in deprescription; and (ii) applying the results of the survey to a panel of experts to obtain a consensus. Results: The deprescription process is influenced by the interaction of three pillars of older adult health care: the prescriber, the patient-family, and the health care system. In the professional and health care systems, professional training and communication skills, prolonged clinical follow-up, access to the multidisciplinary team, medical consultations of an adequate time, and unified electronic health records were identified as facilitators of deprescription. In the patient-family pillar, clear facilitators included health literacy, no sensory or cognitive deficits, and a clinical situation of transitional or palliative care. Conclusions: Deprescription is a complex, multifactorial process that requires attention, time, and specific skills and competencies from the attending physician, but it also requires shared decision-making and a health system compatible with a culture of deprescription.
- Open Access
- 15 March 2021
- Published by Revista Brasileira de Farmacia Hospitalar e Servicos de Saude in Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
- Vol. 12 (1) , 602
Adverse drug events: description of an active search process in a teaching hospital of the Sentinela Network
Objective: To describe the implementation of an active search service for adverse drug events (ADE) in a teaching hospital in the Midwest region of Brazil. Method: Observational sectional study conducted at the Pharmacovigilance Service in a University hospital in the Midwest Region of Brazil, from March to August/2019. All patients admitted to a medical clinic unit were included and those who did not find medical records were excluded. A work process structured in six stages was elaborated: 1) elaboration of a list of triggers through literature review; 2) elaboration of a list of patients whose previously selected triggers appeared; 3) visiting the wards and reviewing medical records; 4) validation of ADE; 5) notification of ADE to Agência Nacional de Vigilância Sanitária; 6) registration of information in databases. Results: The Positive Predictive Value (PPV) of each tracker was calculated individually and globally. The relative and absolute frequency of ADE was calculated as to the type, description and the drug involved. A total of 479 searches were made in the period and the frequency of ADE was 7.48%. The global triggers PPV was 0.04. The trigger with the best performance was promethazine (1.00), followed by the Activated Partial Thromboplastin Time (0.67). Regarding the identified ADE, it was observed that most of the time, 24.14% were related to infusion reactions. It was observed that 53.85% of the drugs involved in ADE were high alert medications. Conclusion: It was observed that the implementation of an active search service for ADE in hospitals that do not have the support of an electronic medical record system is feasible to be performed. It was also observed a high frequency of ADE and that the active search guided by triggers allows to identify events that otherwise could not be identified.
- 15 March 2021
- Published by Revista Brasileira de Farmacia Hospitalar e Servicos de Saude in Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
- Vol. 12 (1) , 602
Open AccessAdverse drug events: description of an active search process in a teaching hospital of the Sentinela Network
Objective: To describe the implementation of an active search service for adverse drug events (ADE) in a teaching hospital in the Midwest region of Brazil. Method: Observational sectional study conducted at the Pharmacovigilance Service in a University hospital in the Midwest Region of Brazil, from March to August/2019. All patients admitted to a medical clinic unit were included and those who did not find medical records were excluded. A work process structured in six stages was elaborated: 1) elaboration of a list of triggers through literature review; 2) elaboration of a list of patients whose previously selected triggers appeared; 3) visiting the wards and reviewing medical records; 4) validation of ADE; 5) notification of ADE to Agência Nacional de Vigilância Sanitária; 6) registration of information in databases. Results: The Positive Predictive Value (PPV) of each tracker was calculated individually and globally. The relative and absolute frequency of ADE was calculated as to the type, description and the drug involved. A total of 479 searches were made in the period and the frequency of ADE was 7.48%. The global triggers PPV was 0.04. The trigger with the best performance was promethazine (1.00), followed by the Activated Partial Thromboplastin Time (0.67). Regarding the identified ADE, it was observed that most of the time, 24.14% were related to infusion reactions. It was observed that 53.85% of the drugs involved in ADE were high alert medications. Conclusion: It was observed that the implementation of an active search service for ADE in hospitals that do not have the support of an electronic medical record system is feasible to be performed. It was also observed a high frequency of ADE and that the active search guided by triggers allows to identify events that otherwise could not be identified.
- Open Access
- 20 October 2020
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 88 (4) , 48
Prevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial
The prevalence of obesity is increasing worldwide and is commonly associated with comorbidities. The use of several drugs is often necessary, which leads to Potential Drug Interactions (PDI) that may increase the morbidity and mortality. This study aimed to analyze the prevalence of drug interaction and its association with socio-demographics, health status, and drug use in severely obese individuals. Baseline data from a randomized clinical trial registered at Clinicaltrial.gov (NCT02463435) were used. A total of 150 individuals aged 18–65 years with a body mass index of 35 kg/m2 were included. The outcome variable was the presence of PDI, and the explanatory variables were divided into the following four levels: socio-demographic, lifestyle, health, and medication use. The prevalence of PDI was 50% (n = 75) (95% CI 41–58). The variables associated with drug–drug interactions in the multiple analyses were arterial hypertension (PR 1.83, 95%, CI 1.10–3.04), polypharmacy (PR 3.12, 95%, CI 2.17–4.50), and diabetes mellitus (PR 0.60, 95%, CI 0.45–0.81). The risk factors for the occurrence of drug interaction were the presence of diabetes mellitus, hypertension, and polypharmacy.
- 20 October 2020
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 88 (4) , 48
Open AccessPrevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial
The prevalence of obesity is increasing worldwide and is commonly associated with comorbidities. The use of several drugs is often necessary, which leads to Potential Drug Interactions (PDI) that may increase the morbidity and mortality. This study aimed to analyze the prevalence of drug interaction and its association with socio-demographics, health status, and drug use in severely obese individuals. Baseline data from a randomized clinical trial registered at Clinicaltrial.gov (NCT02463435) were used. A total of 150 individuals aged 18–65 years with a body mass index of 35 kg/m2 were included. The outcome variable was the presence of PDI, and the explanatory variables were divided into the following four levels: socio-demographic, lifestyle, health, and medication use. The prevalence of PDI was 50% (n = 75) (95% CI 41–58). The variables associated with drug–drug interactions in the multiple analyses were arterial hypertension (PR 1.83, 95%, CI 1.10–3.04), polypharmacy (PR 3.12, 95%, CI 2.17–4.50), and diabetes mellitus (PR 0.60, 95%, CI 0.45–0.81). The risk factors for the occurrence of drug interaction were the presence of diabetes mellitus, hypertension, and polypharmacy.
- Open Access
- 23 September 2020
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 88 (4) , 41
Prevalence of Adverse Drug Events in Severely Obese Adults and Associated Factors: Clinical Trial Baseline Results
Drugs are the most widely used therapeutic tool for treatment of diseases. However, misuse can lead to an adverse drug event (ADE) in susceptible individuals such as those that are severely obese. This study aimed to describe the frequency of ADEs, the associations of ADEs with anatomical therapeutic chemical classes and their respective frequency, estimate the prevalence of ADEs, and analyse factors associated with ADE in adults with severe obesity. Cross-sectional analysis of baseline data from a randomized clinical trial in the central-western region of Brazil. A total of 150 individuals aged 18–65 years with a Body Mass Index of 35 kg/m2 were included. The outcome variable was the presence of ADE and the explanatory variables were socio-demographic factors, lifestyle, health, and medication use. ADEs were associated with use of drugs for the digestive tract and metabolism (p < 0.001) and the cardiovascular system (p < 0.001). The prevalence of ADEs was 32.67% (n = 49) and associated with the age range 40 to 49 years (p = 0.033), diabetes (p = 0.004), multimorbidities ≥ 4 (p = 0.009), self-medication (0.031), and presence of potential drug interactions (0.017). The prevalence of ADEs was high and was associated with drugs commonly used in treatment of obesity-related morbidities and self-medication. The introduction of a pharmacist to multi-professional teams can improve medication safety for severely obese patients.
- 23 September 2020
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 88 (4) , 41
Open AccessPrevalence of Adverse Drug Events in Severely Obese Adults and Associated Factors: Clinical Trial Baseline Results
Drugs are the most widely used therapeutic tool for treatment of diseases. However, misuse can lead to an adverse drug event (ADE) in susceptible individuals such as those that are severely obese. This study aimed to describe the frequency of ADEs, the associations of ADEs with anatomical therapeutic chemical classes and their respective frequency, estimate the prevalence of ADEs, and analyse factors associated with ADE in adults with severe obesity. Cross-sectional analysis of baseline data from a randomized clinical trial in the central-western region of Brazil. A total of 150 individuals aged 18–65 years with a Body Mass Index of 35 kg/m2 were included. The outcome variable was the presence of ADE and the explanatory variables were socio-demographic factors, lifestyle, health, and medication use. ADEs were associated with use of drugs for the digestive tract and metabolism (p < 0.001) and the cardiovascular system (p < 0.001). The prevalence of ADEs was 32.67% (n = 49) and associated with the age range 40 to 49 years (p = 0.033), diabetes (p = 0.004), multimorbidities ≥ 4 (p = 0.009), self-medication (0.031), and presence of potential drug interactions (0.017). The prevalence of ADEs was high and was associated with drugs commonly used in treatment of obesity-related morbidities and self-medication. The introduction of a pharmacist to multi-professional teams can improve medication safety for severely obese patients.
- Open Access
- 11 March 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (4) , e184942650
A cultura de segurança do paciente em um hospital público de urgência e emergência
A cultura de segurança é o produto de atitudes, competências e padrões comportamentais, que são determinantes na forma com que os profissionais vão aderir aos serviços de saúde, para a redução máxima de danos e riscos evitáveis. O objetivo desta pesquisa foi de conhecer a percepção dos profissionais em relação à cultura de segurança do paciente. Realizou-se um estudo transversal analítico com profissionais da assistência ao paciente. Foi aplicado o questionário “Pesquisa sobre Segurança do Paciente em Hospitais”. As dimensões com os porcentuais de respostas positivas mais elevadas foram “Expectativas e ações do seu supervisor na promoção da segurança do paciente”, “Promoção e aprendizado contínuo” e “Trabalho em equipe na unidade”. Apesar das fragilidades, nota-se o empenho da gestão em ações ativas para o fortalecimento da segurança do paciente.
- 11 March 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (4) , e184942650
Open AccessA cultura de segurança do paciente em um hospital público de urgência e emergência
A cultura de segurança é o produto de atitudes, competências e padrões comportamentais, que são determinantes na forma com que os profissionais vão aderir aos serviços de saúde, para a redução máxima de danos e riscos evitáveis. O objetivo desta pesquisa foi de conhecer a percepção dos profissionais em relação à cultura de segurança do paciente. Realizou-se um estudo transversal analítico com profissionais da assistência ao paciente. Foi aplicado o questionário “Pesquisa sobre Segurança do Paciente em Hospitais”. As dimensões com os porcentuais de respostas positivas mais elevadas foram “Expectativas e ações do seu supervisor na promoção da segurança do paciente”, “Promoção e aprendizado contínuo” e “Trabalho em equipe na unidade”. Apesar das fragilidades, nota-se o empenho da gestão em ações ativas para o fortalecimento da segurança do paciente.
- Open Access
- 3 February 2020
- Published by Springer Nature in BMC Health Services Research
- Vol. 20 (1) , 1-14
Institutional strategies as a mechanism to rationalize the negative effects of the judicialization of access to medicine in Brazil
Background: Recently, the Executive Branch and Judiciary in Brazil increased spending due to larger numbers of lawsuits that forced the State to provide health goods and services. This phenomenon, known as health judicialization, has created challenges and required the Executive Branch and Judiciary to create institutional strategies such as technical chambers and departments to reduce the social, economic and political distortions caused by this phenomenon. This study aims to evaluate the effects of two institutional strategies deployed by a Brazilian municipality in order to cope with the economic, social and political distortions caused by the phenomenon of health judicialization regarding access to medicines. Methods: A longitudinal study was carried out in a capital in the Central-West Region of Brazil. A sample of 511 lawsuits was analyzed. The variables were placed into three groups: the sociodemographic characteristics and the plaintiffs’ disease, the characteristics of the claimed medical products and the institutional strategies. To analyze the effect of the interventions on the total cost of the medicines in the lawsuits, bivariate and multivariate linear regressions with variance were performed. For the categorical outcomes, Poisson regressions were performed with robust variance, using a significance level of 5%. Results: A reduction in the costs of medicines in the lawsuits and of the requests for medicines within the SUS formulary was verified after the deployment of the Department of Assessment of Nonstandardized Medicines (DAMNP) and the Technical Chamber of Health Assessment (CATS); an increase in processed prescriptions from the Brazilian Universal Health System was observed after the deployment of the CATS; and an increase in medicines outside the SUS formulary without a therapeutic alternative was verified after the CATS. Conclusion: The institutional strategies deployed were important tools to reduce the high costs of the medicines in the lawsuits. In addition, they represented a step forward for the State, provided a benefit to society and indicated a potential path for the health and justice systems of other countries that also face problems caused by the judicialization of health.
- 3 February 2020
- Published by Springer Nature in BMC Health Services Research
- Vol. 20 (1) , 1-14
Open AccessInstitutional strategies as a mechanism to rationalize the negative effects of the judicialization of access to medicine in Brazil
Background: Recently, the Executive Branch and Judiciary in Brazil increased spending due to larger numbers of lawsuits that forced the State to provide health goods and services. This phenomenon, known as health judicialization, has created challenges and required the Executive Branch and Judiciary to create institutional strategies such as technical chambers and departments to reduce the social, economic and political distortions caused by this phenomenon. This study aims to evaluate the effects of two institutional strategies deployed by a Brazilian municipality in order to cope with the economic, social and political distortions caused by the phenomenon of health judicialization regarding access to medicines. Methods: A longitudinal study was carried out in a capital in the Central-West Region of Brazil. A sample of 511 lawsuits was analyzed. The variables were placed into three groups: the sociodemographic characteristics and the plaintiffs’ disease, the characteristics of the claimed medical products and the institutional strategies. To analyze the effect of the interventions on the total cost of the medicines in the lawsuits, bivariate and multivariate linear regressions with variance were performed. For the categorical outcomes, Poisson regressions were performed with robust variance, using a significance level of 5%. Results: A reduction in the costs of medicines in the lawsuits and of the requests for medicines within the SUS formulary was verified after the deployment of the Department of Assessment of Nonstandardized Medicines (DAMNP) and the Technical Chamber of Health Assessment (CATS); an increase in processed prescriptions from the Brazilian Universal Health System was observed after the deployment of the CATS; and an increase in medicines outside the SUS formulary without a therapeutic alternative was verified after the CATS. Conclusion: The institutional strategies deployed were important tools to reduce the high costs of the medicines in the lawsuits. In addition, they represented a step forward for the State, provided a benefit to society and indicated a potential path for the health and justice systems of other countries that also face problems caused by the judicialization of health.